Condition: Atherosclerosis Cardiovascular Disease · ASCVD · ASCVD Management · Sponsor: Atom Therapeutics Co., Ltd
This is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of ABP-745 in patients with ASCVD. Efficacy of ABP-745 in reducing atherosclerotic plaque compared with placebo will be evaluated in participants with ASCVD. The primary efficacy measurement will be assessed at 52W of treatment.
This description comes directly from the study's public registry record.
Qiang Shi · 86+ 19117302212 · qiang.shi@atombp.com
Always discuss trial participation with your own doctor first.
| Cardiovascular Research Foundation of Southern California | Beverly Hills, California, United States | Not Yet Recruiting |
| Cardiovascular Institute of San Diego INC | San Diego, California, United States | Not Yet Recruiting |
| The Lundquist Institute | Torrance, California, United States | Not Yet Recruiting |
| Washington University School of Medicine, St.louis | St Louis, Missouri, United States | Not Yet Recruiting |
| NovaTrails | Newcastle, New South Wales, Australia | Not Yet Recruiting |
| University of the Sunshine Coast Clinical Trials Unit - Morayfield | Morayfield, Queensland, Australia | Not Yet Recruiting |
| Core Research Group Pty Ltd | Brisbane, Australia | Not Yet Recruiting |
| UniSC Clinical Trials (Brisbane) | Brisbane, Australia | Not Yet Recruiting |
| Cognivus | Wahroonga, Australia | Not Yet Recruiting |
| Beijing Friendship Hospital, Capital Medical University | Beijing, China | Not Yet Recruiting |
| Peking Union Medical College Hospital | Beijing, China | Not Yet Recruiting |
| Peking University First Hospital | Beijing, China | Not Yet Recruiting |
+ 21 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07303777